134 related articles for article (PubMed ID: 25869319)
61. New Drugs for Preventing Migraines.
Aschenbrenner DS
Am J Nurs; 2019 May; 119(5):22. PubMed ID: 31033548
[No Abstract] [Full Text] [Related]
62. Not all CGRP antagonists are created equal.
Peroutka SJ
Headache; 2013 Jun; 53(6):1004-6. PubMed ID: 23721243
[No Abstract] [Full Text] [Related]
63. Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation.
Girotra P; Thakur A; Kumar A; Singh SK
Int J Biol Macromol; 2017 Mar; 96():687-696. PubMed ID: 28041915
[TBL] [Abstract][Full Text] [Related]
64. Optimising migraine treatment: from drug-drug interactions to personalized medicine.
Pomes LM; Guglielmetti M; Bertamino E; Simmaco M; Borro M; Martelletti P
J Headache Pain; 2019 May; 20(1):56. PubMed ID: 31101004
[TBL] [Abstract][Full Text] [Related]
65. Calcitonin Gene-Related Peptide Targeted Therapy for Migraine.
Tepper DE
Headache; 2016 Feb; 56(2):447-8. PubMed ID: 26898484
[No Abstract] [Full Text] [Related]
66. Efficacy of BMS-927711 and other gepants vs triptans: there seem to be other players besides CGRP.
Pascual J
Cephalalgia; 2014 Oct; 34(12):1028-9. PubMed ID: 24615704
[No Abstract] [Full Text] [Related]
67. Therapeutic role of monoclonal antibodies in Migraine: A new paradigm.
Ashish K; Faisaluddin M; Bandyopadhyay D; Dhaduk K; Baral A
Eur J Intern Med; 2018 Nov; 57():e9-e10. PubMed ID: 30031595
[No Abstract] [Full Text] [Related]
68. The Future of Migraine Prevention.
Cowan RP
Headache; 2018 Nov; 58 Suppl 3():291-297. PubMed ID: 30311219
[TBL] [Abstract][Full Text] [Related]
69. Anti-CGRP antibodies: a new approach to migraine prevention.
Reuter U
Lancet Neurol; 2014 Sep; 13(9):857-9. PubMed ID: 25127171
[No Abstract] [Full Text] [Related]
70. Challenging chronic migraine: targeting the CGRP receptor.
Giamberardino MA; Costantini R
Lancet Neurol; 2017 Jun; 16(6):410-411. PubMed ID: 28460891
[No Abstract] [Full Text] [Related]
71. CGRP as a new target in prevention and treatment of migraine.
Diener HC
Lancet Neurol; 2014 Nov; 13(11):1065-1067. PubMed ID: 25297015
[No Abstract] [Full Text] [Related]
72. New hope for people with migraine headaches.
Harv Health Lett; 2014 Jul; 39(9):8. PubMed ID: 25314737
[No Abstract] [Full Text] [Related]
73. Migraine mAbs crowd into late-stage trials.
Sinha G
Nat Biotechnol; 2015 Jul; 33(7):676-7. PubMed ID: 26153991
[No Abstract] [Full Text] [Related]
74. Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18.
Sehgal SA; Hassan M; Rashid S
Drug Des Devel Ther; 2014; 8():571-81. PubMed ID: 24899801
[TBL] [Abstract][Full Text] [Related]
75. Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assays.
Sampson JH; Phillipson JD; Bowery NG; O'Neill MJ; Houston JG; Lewis JA
Phytother Res; 2000 Feb; 14(1):24-9. PubMed ID: 10641043
[TBL] [Abstract][Full Text] [Related]
76. Site of effect of LY2951742 for migraine prophylaxis.
Tfelt-Hansen P
Lancet Neurol; 2015 Jan; 14(1):31-2. PubMed ID: 25496894
[No Abstract] [Full Text] [Related]
77. Site of effect of LY2951742 for migraine prophylaxis--authors' reply.
Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS
Lancet Neurol; 2015 Jan; 14(1):32-3. PubMed ID: 25496895
[No Abstract] [Full Text] [Related]
78. Oral Tolerance: Another Reason to Eat Your Veggies!
Hardet R; Mingozzi F
Mol Ther; 2017 Feb; 25(2):311-313. PubMed ID: 28109961
[No Abstract] [Full Text] [Related]
79. Fruits and Veggies.
Kleiner SM
Phys Sportsmed; 1996 Nov; 24(11):97-98. PubMed ID: 29275721
[No Abstract] [Full Text] [Related]
80. The market for migraine drugs.
Sparrow AM; Searles JW
Nat Rev Drug Discov; 2019 Jan; ():. PubMed ID: 31048795
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
